Page last updated: 2024-09-03

omega-n-methylarginine and bendroflumethiazide

omega-n-methylarginine has been researched along with bendroflumethiazide in 1 studies

Compound Research Comparison

Studies
(omega-n-methylarginine)
Trials
(omega-n-methylarginine)
Recent Studies (post-2010)
(omega-n-methylarginine)
Studies
(bendroflumethiazide)
Trials
(bendroflumethiazide)
Recent Studies (post-2010) (bendroflumethiazide)
4,41134433666723944

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lim, PO; MacDonald, TM; Tzemos, N1

Trials

1 trial(s) available for omega-n-methylarginine and bendroflumethiazide

ArticleYear
Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study.
    Circulation, 2001, Jul-31, Volume: 104, Issue:5

    Topics: Acetylcholine; Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Benzopyrans; Blood Pressure; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Endothelium, Vascular; Ethanolamines; Female; Forearm; Humans; Hypertension; Male; Middle Aged; Nebivolol; Nitroprusside; omega-N-Methylarginine; Vasoconstriction; Vasodilation; Vasodilator Agents

2001